Tenax Therapeutics, Inc. (TENX)

Tenax Therapeutics Statistics

Total Valuation

TENX has a market cap or net worth of $365.13 million. The enterprise value is $265.76 million.

Market Cap	365.13M
Enterprise Value	265.76M

Important Dates

The last earnings date was Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

TENX has 40.57 million shares outstanding. The number of shares has increased by 505.18% in one year.

Current Share Class	6.24M
Shares Outstanding	40.57M
Shares Change (YoY)	+505.18%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	0.17%
Owned by Institutions (%)	13.81%
Float	6.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.76
P/TBV Ratio	3.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.58

Current Ratio	15.58
Quick Ratio	15.06
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -44.80% and return on invested capital (ROIC) is -30.52%.

Return on Equity (ROE)	-44.80%
Return on Assets (ROA)	-29.14%
Return on Invested Capital (ROIC)	-30.52%
Return on Capital Employed (ROCE)	-49.09%
Revenue Per Employee	n/a
Profits Per Employee	-$7.22M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +82.93% in the last 52 weeks. The beta is 1.58, so TENX's price volatility has been higher than the market average.

Beta (5Y)	1.58
52-Week Price Change	+82.93%
50-Day Moving Average	7.20
200-Day Moving Average	6.30
Relative Strength Index (RSI)	73.28
Average Volume (20 Days)	78,040

Short Selling Information

The latest short interest is 762,345, so 1.88% of the outstanding shares have been sold short.

Short Interest	762,345
Short Previous Month	754,325
Short % of Shares Out	1.88%
Short % of Float	12.35%
Short Ratio (days to cover)	7.57

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-47.23M
Pretax Income	-43.33M
Net Income	-43.33M
EBITDA	n/a
EBIT	-47.23M
Earnings Per Share (EPS)	-$1.14

Balance Sheet

The company has $99.37 million in cash and n/a in debt, giving a net cash position of $99.37 million or $2.45 per share.

Cash & Cash Equivalents	99.37M
Total Debt	n/a
Net Cash	99.37M
Net Cash Per Share	$2.45
Equity (Book Value)	96.21M
Book Value Per Share	2.39
Working Capital	96.21M

Cash Flow

Operating Cash Flow	-25.91M
Capital Expenditures	n/a
Free Cash Flow	-25.91M
FCF Per Share	-$0.64

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TENX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-505.18%
Shareholder Yield	-505.18%
Earnings Yield	-11.87%
FCF Yield	-7.10%

Analyst Forecast

The average price target for TENX is $17.00, which is 88.89% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$17.00
Price Target Difference	88.89%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-7.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 3, 2024. It was a reverse split with a ratio of 1:80.

Last Split Date	Jan 3, 2024
Split Type	Reverse
Split Ratio	1:80

Scores

Altman Z-Score	n/a
Piotroski F-Score	1